Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-11-04
1997-02-18
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
564 99, A61K 31165, C07C31112
Patent
active
056042604
ABSTRACT:
The Compound of Formula I and pharmaceutically acceptable salts thereof in the treatment of cyclooxygenase-2 mediated diseases are disclosed.
REFERENCES:
patent: 2646385 (1953-07-01), Lewenstein
patent: 3010873 (1961-11-01), Cavallini et al.
patent: 3121044 (1964-02-01), Buckwalter et al.
patent: 3128226 (1964-04-01), Rubin et al.
patent: 3439094 (1969-04-01), Emele
patent: 3840597 (1974-10-01), Moore et al.
patent: 4244960 (1981-01-01), Schroder et al.
patent: 4375479 (1983-03-01), Schroeder et al.
patent: 4820827 (1989-04-01), Haber
patent: 4866091 (1989-09-01), Matsuo et al.
patent: 4885367 (1989-12-01), Yoshikawa et al.
patent: 5409944 (1995-04-01), Black et al.
Boyce, et al., "A Selective Inhibitor of Cyclooxygenase-2 Elicits Antinociception But Not Gastric Ulceration in Rats", Neuropharmacology, vol. 33, (12), pp. 1609-1611 (1994).
Wiesenberg-Bottcher, et al., "The Pharmacological Profile of CGP 28238, a Highly Potent Anti-Inflammatory Compound", Agents and Actions, vol. 26, pp. 240-242 (1989).
Lombardino, et al., "Acidic Antiinflammatory Agents--Correlations of Some Physical, Pharmacological and Clinical Data", Arzneim.-Forsch.(Drug Res.), vol. 25 Nr. 10, pp. 1629-1635 (1975).
Lombardino, "Laboratory Models for Testing Nonsteroidal Antiinflammatory Drugs", Nonsteroidal Antiinflammatory Drugs, pp. 114-130, (1985).
National Meeting of the American Chemical Society, Washington, D.C., USA, Aug. 21-25, 1994. Abstracts of Papers American Chemical Society 208 (1-2), 1994 MEDI 272 ISSN:0065-7727.
National Meeting of the American Chemical Society, Washington, D.C., USA, Aug. 21-25, 1994. Abstracts of Papers American Chemical Society 208 (1-2), 1994 MEDI 116 ISSN: 0065-7727.
D. P. Carr, et al., Agents and Actions, vol. 19, 5/6 (1986) pp. 374-375, "Comparison of the systemic inhibition of thromboxane synthesis, anti-inflammatory activity and gastro-intestinal toxicity . . . ".
Chem Abstracts vol. 100, (1) AB. #6113u, (1983).
Chem Abstracts vol. 104, (1985) AB #107904r.
Chem Abstracts vol. 113 (1990) AB. #224303r.
Chem Abstracts vol. 106, (1987) AB. #60922u.
Chem Abstracts vol. 110, (1989) AB. #128249v.
Gans, et al, Journal of Pharm. and Expirim. Ther., vol. 254, No. 1, pp. 180-187 (1990).
Hla, et al, Proc. Natl. Acad. Sci, vol. 89, pp. 7384-7388 Pharmacology Aug. (1992).
Rufer, et al, Eur. J. Med. Chem. Chim. Ther., vol. 17, pp. 173-180 (1982).
Guay Daniel
Li Chun-Sing
Henley III Raymond
Merck Frosst Canada Inc.
Panzer Curtis C.
Rose David L.
Spivack Phyllis G.
LandOfFree
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygena does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygena, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygena will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1602865